Julie Xing
Director/Board Member at APTARGROUP, INC.
Net worth: 387 927 $ as of 30/03/2024
Profile
Julie Xing is currently the Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd.
and an Independent Director at AptarGroup, Inc. She previously worked at Eli Lilly & Co. as the Senior Director-Global New Product Planning from 2010 to 2019.
Julie also held positions at Panomics LLC as the VP, GM-Asia Pacific & Japan Operations, and at Envista Holdings Corp.
as the Global Senior VP & President-Greater China.
She holds a doctorate degree from The Hong Kong University of Science & Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
APTARGROUP, INC.
0.00% | 30/04/2024 | 2,696 ( 0.00% ) | 387 927 $ | 30/03/2024 |
Julie Xing active positions
| Companies | Position | Start |
|---|---|---|
| APTARGROUP, INC. | Director/Board Member | 28/02/2023 |
Mundipharma (China) Pharmaceutical Co., Ltd.
 Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Chairman | 28/02/2023 |
Former positions of Julie Xing
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 31/12/2018 |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
| ENVISTA HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Training of Julie Xing
| The Hong Kong University of Science & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| APTARGROUP, INC. | Process Industries |
| ELI LILLY AND COMPANY | Health Technology |
| ENVISTA HOLDINGS CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Julie Xing
